Health knowledge made personal
Join this community!
› Share page:
Search posts:

Good news for treating staph.... ...

Posted Nov 10 2008 4:23pm

Good news for treating staph....BD  

Johnson & Johnson Pharmaceutical Research & Development, L.L.C., announced that the investigational antibiotic ceftobiprole was as effective as commonly used combination therapy in treating patients with complicated skin infections caused by a broad spectrum of bacteria. Ceftobiprole also was found to clinically cure more than 90% of patients who had infections caused by Staphylococcus aureus (S. aureus), including patients with complicated skin infections due to PVL- positive methicillin-resistant S. aureus (MRSA). These new data were presented in two posters at the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).

New Data Show Ceftobiprole As Effective As Combination Therapy In Treating Patients With Complicated Skin Infections, Including MRSA

Post a comment
Write a comment: